Advertisement

Journal of Endocrinological Investigation

, Volume 38, Issue 7, pp 761–767 | Cite as

Surgical menopause versus natural menopause and cardio-metabolic disturbances: A 12-year population-based cohort study

  • M. Farahmand
  • F. Ramezani TehraniEmail author
  • M. Bahri Khomami
  • M. Noroozzadeh
  • F. Azizi
Original Article

Abstract

Purpose

Menopausal status exposes women to increased risk of cardiovascular disease. This study was performed to compare the effect of menopausal types, including surgical and natural, on metabolic syndrome and other metabolic disorders 3 years before and after menopause.

Methods

Of 437 postmenopausal women, who participated in the Tehran Lipid and Glucose Study, 13 women with surgical menopause and 39 age-matched controls with natural menopause were selected. During the follow-up period, changes in metabolic and biochemical profiles were compared between surgical and natural menopause women.

Results

Odds of incidence of metabolic syndrome in surgical menopause women, compared to natural menopause women, was 9.7 (95 % CI 1.8–51.8).

Conclusions

Metabolic disturbances after menopause are highly influenced by type of menopause and are more prevalent in those undergoing surgical menopause.

Keywords

Natural menopause Surgical menopause Metabolic syndrome Tehran Lipid and Glucose Study 

Notes

Acknowledgments

We appreciate the substantial time and effort the study participants contributed to this study. Acknowledgments are also due to research staff at the Tehran Lipid and Glucose Study Unit and staff of the Research Endocrine Laboratory. Also we thank Mrs. N. Shiva for critical editing of English grammar and syntax of the manuscript. We thank the National Council of Scientific Research of the Islamic Republic of Iran for approval of this project and for its funding as a national research project.

Conflict of interest

The authors declare that there are no competing interests and that the source of funding is independent of the objectives and results found in this study.

Ethical approval

Ethical code: 750 EC 90/11/16. The ethical review board of the Research Institute for Endocrine Sciences approved the study proposal.

Informed Consent

Informed consent was obtained from all subjects.

References

  1. 1.
    Zachariasen RD (1995) Oral manifestations of bulimia nervosa. Women Health 22:67–76PubMedCrossRefGoogle Scholar
  2. 2.
    Sitruk-Ware R, Ibarra de Palacios P (1989) Oestrogen replacement therapy and cardiovascular disease in post-menopausal women. A review. Maturitas. 11:259–274PubMedCrossRefGoogle Scholar
  3. 3.
    Kulak J Jr, Urbanetz AA, Kulak CA, Borba VZ, Boguszewski CL (2009) Serum androgen concentrations and bone mineral density in postmenopausal ovariectomized and non-ovariectomized women. Arq Bras Endocrinol Metabol 53:1033–1039PubMedCrossRefGoogle Scholar
  4. 4.
    Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH (1987) Menopause and the risk of coronary heart disease in women. N Engl J Med 316:1105–1110PubMedCrossRefGoogle Scholar
  5. 5.
    Kannel WB, Wilson PW (1995) Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 155:57–61PubMedCrossRefGoogle Scholar
  6. 6.
    Expert Panel on Detection E, Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel 3), pp 2486–2497Google Scholar
  7. 7.
    Wilson PW, Kannel WB, Silbershatz H, D’Agostino RB (1999) Clustering of metabolic factors and coronary heart disease. Arch Intern Med 159:1104–1109PubMedCrossRefGoogle Scholar
  8. 8.
    Figueiredo Neto JA, Figueredo ED, Barbosa JB, Barbosa Fde F, Costa GR, Nina VJ et al (2010) Metabolic syndrome and menopause: cross-sectional study in gynecology clinic. Arq Bras Cardiol 95:339–345PubMedCrossRefGoogle Scholar
  9. 9.
    Hidalgo LA, Chedraui PA, Morocho N, Alvarado M, Chavez D, Huc A (2006) The metabolic syndrome among postmenopausal women in Ecuador. Gynecol Endocrinol 22:447–454PubMedCrossRefGoogle Scholar
  10. 10.
    Kannel WB, Hjortland MC, McNamara PM, Gordon T (1976) Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 85:447–452PubMedCrossRefGoogle Scholar
  11. 11.
    Davis CE, Pajak A, Rywik S, Williams DH, Broda G, Pazucha T et al (1994) Natural menopause and cardiovascular disease risk factors. The Poland and US Collaborative Study on Cardiovascular Disease Epidemiology. Ann Epidemiol 4:445–448PubMedCrossRefGoogle Scholar
  12. 12.
    Akahoshi M, Soda M, Nakashima E, Shimaoka K, Seto S, Yano K (1996) Effects of menopause on trends of serum cholesterol, blood pressure, and body mass index. Circulation 94:61–66PubMedCrossRefGoogle Scholar
  13. 13.
    Sowers M, Crawford SL, Cauley JA, Stein E (2003) Association of lipoprotein(a), insulin resistance, and reproductive hormones in a multiethnic cohort of pre- and perimenopausal women (The SWAN Study). Am J Cardiol 92:533–537PubMedCrossRefGoogle Scholar
  14. 14.
    Matthews KA, Wing RR, Kuller LH, Meilahn EN, Plantinga P (1994) Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch Intern Med 154:2349–2355PubMedCrossRefGoogle Scholar
  15. 15.
    Heinrich J, Sandkamp M, Kokott R, Schulte H, Assmann G (1991) Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population. Clin Chem 37:1950–1954PubMedGoogle Scholar
  16. 16.
    Jenner JL, Ordovas JM, Lamon-Fava S, Schaefer MM, Wilson PW, Castelli WP et al (1993) Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study. Circulation. 87:1135–1141PubMedCrossRefGoogle Scholar
  17. 17.
    Landgren BM, Collins A, Csemiczky G, Burger HG, Baksheev L, Robertson DM (2004) Menopause transition: annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause. J Clin Endocrinol Metab 89:2763–2769PubMedCrossRefGoogle Scholar
  18. 18.
    Davison SL, Bell R, Donath S, Montalto JG, Davis SR (2005) Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90:3847–3853PubMedCrossRefGoogle Scholar
  19. 19.
    Ozdemir S, Celik C, Gorkemli H, Kiyici A, Kaya B (2009) Compared effects of surgical and natural menopause on climacteric symptoms, osteoporosis, and metabolic syndrome. Int J Gynaecol Obstet 106:57–61PubMedCrossRefGoogle Scholar
  20. 20.
    Weinberg ME, Manson JE, Buring JE, Cook NR, Seely EW, Ridker PM et al (2006) Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism. 55:1473–1480PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Demirovic J, Sprafka JM, Folsom AR, Laitinen D, Blackburn H (1992) Menopause and serum cholesterol: differences between blacks and whites. The Minnesota Heart Survey. Am J Epidemiol 136:155–164PubMedGoogle Scholar
  22. 22.
    WHO (1999) Research on the menopause. Word Health Organization, GenevaGoogle Scholar
  23. 23.
    Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRefGoogle Scholar
  24. 24.
    Azizi F, Hadaegh F, Khalili D, Esteghamati A, Hosseinpanah F, Delavari A et al (2010) Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med. 13:426–428PubMedGoogle Scholar
  25. 25.
    Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352:2477–2486PubMedCrossRefGoogle Scholar
  26. 26.
    Lawrence JM, Contreras R, Chen W, Sacks DA (2008) Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999–2005. Diabetes Care 31:899–904PubMedCrossRefGoogle Scholar
  27. 27.
    Carr DB, Utzschneider KM, Hull RL, Tong J, Wallace TM, Kodama K et al (2006) Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care 29:2078–2083PubMedCrossRefGoogle Scholar
  28. 28.
    Anastasiou E, Lekakis JP, Alevizaki M, Papamichael CM, Megas J, Souvatzoglou A et al (1998) Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 21:2111–2115PubMedCrossRefGoogle Scholar
  29. 29.
    Das N, Kay VJ, Mahmood TA (2003) Current knowledge of risks and benefits of prophylactic oophorectomy at hysterectomy for benign disease in United Kingdom and Republic of Ireland. Eur J Obstet Gynecol Reprod Biol 109:76–79PubMedCrossRefGoogle Scholar
  30. 30.
    Dorum A, Tonstad S, Liavaag AH, Michelsen TM, Hildrum B, Dahl AA (2008) Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2). Gynecol Oncol 109:377–383PubMedCrossRefGoogle Scholar
  31. 31.
    Gierach GL, Johnson BD, Bairey Merz CN, Kelsey SF, Bittner V, Olson MB et al (2006) Hypertension, menopause, and coronary artery disease risk in the Women’s Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 47:S50–S58PubMedCrossRefGoogle Scholar
  32. 32.
    Staessen JA, Ginocchio G, Thijs L, Fagard R (1997) Conventional and ambulatory blood pressure and menopause in a prospective population study. J Hum Hypertens 11:507–514PubMedCrossRefGoogle Scholar
  33. 33.
    Farahmand M, Ramezani Tehrani F, Simbar M, Mehrabi Y, Khalili D, Azizi F (2014) Does metabolic syndrome or its components differ in naturally and surgically menopausal women? J Climacteric 17:348–355CrossRefGoogle Scholar
  34. 34.
    Perez-Lopez FR, Chedraui P, Gilbert JJ, Perez-Roncero G (2009) Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women’s Health Initiative era. Fertil Steril 92:1171–1186PubMedCrossRefGoogle Scholar
  35. 35.
    Samsioe G, Lidfeldt J, Nerbrand C, Nilsson P (2010) The women’s health in the Lund area (WHILA) study—an overview. Maturitas 65:37–45PubMedCrossRefGoogle Scholar
  36. 36.
    Portaluppi F, Pansini F, Manfredini R, Mollica G (1997) Relative influence of menopausal status, age, and body mass index on blood pressure. Hypertension 29:976–979PubMedCrossRefGoogle Scholar
  37. 37.
    Zanchetti A, Facchetti R, Cesana GC, Modena MG, Pirrelli A, Sega R (2005) Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens 23:2269–2276PubMedCrossRefGoogle Scholar
  38. 38.
    Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ et al (1998) Abdominal adiposity and coronary heart disease in women. JAMA 280:1843–1848PubMedCrossRefGoogle Scholar
  39. 39.
    Schubert CM, Rogers NL, Remsberg KE, Sun SS, Chumlea WC, Demerath EW et al (2006) Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age: the Fels Longitudinal Study. Int J Obes (Lond). 30:251–260CrossRefGoogle Scholar
  40. 40.
    Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR (1989) Menopause and risk factors for coronary heart disease. N Engl J Med 321:641–646PubMedCrossRefGoogle Scholar
  41. 41.
    Torng PL, Su TC, Sung FC, Chien KL, Huang SC, Chow SN et al (2002) Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight—the Chin-Shan Community Cardiovascular Cohort study. Atherosclerosis. 161:409–415PubMedCrossRefGoogle Scholar
  42. 42.
    Folsom AR, Li Y, Rao X, Cen R, Zhang K, Liu X et al (1994) Body mass, fat distribution and cardiovascular risk factors in a lean population of south China. J Clin Epidemiol 47:173–181PubMedCrossRefGoogle Scholar
  43. 43.
    van Beresteijn EC, Korevaar JC, Huijbregts PC, Schouten EG, Burema J, Kok FJ (1993) Perimenopausal increase in serum cholesterol: a 10-year longitudinal study. Am J Epidemiol 137:383–392PubMedGoogle Scholar
  44. 44.
    Lindquist O (1982) Intraindividual changes of blood pressure, serum lipids, and body weight in relation to menstrual status: results from a prospective population study of women in Goteborg, Sweden. Prev Med. 11:162–172PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2015

Authors and Affiliations

  • M. Farahmand
    • 1
  • F. Ramezani Tehrani
    • 1
    Email author
  • M. Bahri Khomami
    • 1
  • M. Noroozzadeh
    • 1
  • F. Azizi
    • 2
  1. 1.Reproductive Endocrinology Research CenterResearch Institute for Endocrine Sciences, Shahid Beheshti University of Medical SciencesTehranIslamic Republic of Iran
  2. 2.Endocrine Research CenterResearch Institute for Endocrine Sciences, Shahid Beheshti University of Medical SciencesTehranIslamic Republic of Iran

Personalised recommendations